Clinical Trial Detail

NCT ID NCT03761095
Title A Study of PTC596 in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors PTC Therapeutics
Indications

leiomyosarcoma

Therapies

Dacarbazine + PTC596

Age Groups: senior adult

No variant requirements are available.